MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-127

  1. 1,050 Posts.
    lightbulb Created with Sketch. 388
    In relation to nuvaring approval by FDA - it is so corrupt that you can assume things are being held up due to some “friction”. The last issue was to do with packaging. MYX JUST HAVE TO BE NICE TO AVOID HAVING ALL THERE SUBMISSIONS DEALT WITH UNREASONABLY.MYX WOULD KNOW HOW TO SUBMIT PILLS ….they work with companies and assist them to get approvals in there research side etc
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.13 $5.15 $5.08 $445.2K 87.01K

Buyers (Bids)

No. Vol. Price($)
1 810 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.15 2033 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.